Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein.
DNA vaccination may represent an interesting strategy for early life immunization. However, in some cases, this approach has been shown to induce a tolerance rather than immunity. We have compared the efficiency of neonatal DNA or protein immunization against hepadnavirus envelope protein using the duck hepatitis B virus (DHBV) model. Three-day-old ducklings were immunized with either a plasmid encoding the DHBV pre-S/S large envelope protein (L), or a recombinant preS protein, followed by sequential DNA or protein boosts at weeks 4 and 15. Our results showed that genetic immunization of duck neonates induced specific humoral response to DHBV L protein. Interestingly, an enhanced antibody response was elicited when animals received DNA priming-DNA boosting as compared to DNA priming-protein boosting.
Rollier
C
C
Unité de Recherche sur les Virus des Hépatites et les Pathologies Associées, Institut National de la Santé et de la Recherche Médicale unité 271, Lyon, France.
Charollois
C
C
Jamard
C
C
Trepo
C
C
Cova
L
L
D000818:Animals; D000831:Animals, Newborn / Q000276:immunology*; D004372:Ducks; D006508:Hepatitis Antibodies / Q000097:blood*; D015611:Hepatitis B Virus, Duck / Q000276:immunology*; D007114:Immunization; D007115:Immunization Schedule; D019444:Vaccines, DNA / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D006508:Hepatitis Antibodies; D019444:Vaccines, DNA; D014759:Viral Envelope Proteins; D014765:Viral Vaccines